evidence table
Cocoa Flavanol Exercise Performance Randomized Trial Evidence Table
Structured evidence table for Cocoa Flavanol Exercise Performance Randomized Trial, generated from 2 reusable source documents in the Migaku knowledge base.
| topic | claim | evidence level | citation | source |
|---|---|---|---|---|
| Cocoa Flavanol Exercise Performance Randomized Trial | MetS is a multifactorial condition, with its primary indicators including obesity, hypertension, dyslipidemia, insulin resistance, and hyperglycemia; i.e., a patient who possesses at least 3 of the following parameters is designated with MetS: glucose intolerance, increased levels of triglycerides, augmented waist circumference, low levels of high-density lipoprotein cholesterol (HDL-c), and hypertension [,,]. | 3 | Tomaru Júlia Mayumi (2026) | Beyond Taste: The Impact of Chocolate on Cardiovascular and Steatotic Liver Disease Risk Factors |
| Cocoa Flavanol Exercise Performance Randomized Trial | It is possible to develop a close relationship with MetS, metabolic dysfunction-associated steatotic liver disease (MASLD), and CVD [,]. | 3 | Tomaru Júlia Mayumi (2026) | Beyond Taste: The Impact of Chocolate on Cardiovascular and Steatotic Liver Disease Risk Factors |
| Cocoa Flavanol Exercise Performance Randomized Trial | MASLD is strongly associated with various conditions, including MetS, and is characterized by the persistence of a chronic inflammatory state detrimental to the organism [,]. | 3 | Tomaru Júlia Mayumi (2026) | Beyond Taste: The Impact of Chocolate on Cardiovascular and Steatotic Liver Disease Risk Factors |
| Cocoa Flavanol Exercise Performance Randomized Trial | 1 2 3 4 5 6 7 8 9 10 11 12 13 14 Metabolic disorders are increasing sharply due to severe modifications in lifestyle [,,,]. | 3 | Tomaru Júlia Mayumi (2026) | Beyond Taste: The Impact of Chocolate on Cardiovascular and Steatotic Liver Disease Risk Factors |
| Cocoa Flavanol Exercise Performance Randomized Trial | 1 2 3 3 3 4 5 6 The characteristics of dementia syndrome are cognitive dysfunction, including memory loss, reduced executive functions, language impairment, and affected performance in daily life activities []. | 4 | Sbai Oualid (2026) | The Role of Polyphenols on Cognitive Function and Dementia Through Gut–Microbiota–Brain Axis Modulation: A Narrative Review |
| Cocoa Flavanol Exercise Performance Randomized Trial | Notably, about 70% of older people are living in low–middle income countries [], representing a significant economic weight associated with medical costs for health systems []. | 4 | Sbai Oualid (2026) | The Role of Polyphenols on Cognitive Function and Dementia Through Gut–Microbiota–Brain Axis Modulation: A Narrative Review |
| Cocoa Flavanol Exercise Performance Randomized Trial | In addition, it is necessary to unveil the risk factors promoting dementia in order to develop preventive strategies. | 4 | Sbai Oualid (2026) | The Role of Polyphenols on Cognitive Function and Dementia Through Gut–Microbiota–Brain Axis Modulation: A Narrative Review |
| Cocoa Flavanol Exercise Performance Randomized Trial | Dementia affects approximately 55 million individuals worldwide, and its prevalence is expected to rise up to 131.5 million by 2050, representing a major global health challenge [,]. | 4 | Sbai Oualid (2026) | The Role of Polyphenols on Cognitive Function and Dementia Through Gut–Microbiota–Brain Axis Modulation: A Narrative Review |
Source documents